Danica Pension Livsforsikringsaktieselskab Purchases New Position in MetLife, Inc. $MET

Posted by George Bondi on Aug 19th, 2026

Danica Pension Livsforsikringsaktieselskab purchased a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 123,704 shares of the financial services provider’s stock, valued at approximately $10,467,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in MET. Vanguard Group Inc. increased its holdings in shares of MetLife by 12.1% during the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock valued at $5,727,518,000 after purchasing an additional 7,805,814 shares in the last quarter. BlackRock Inc. acquired a new stake in MetLife during the second quarter valued at $4,381,692,000. Pzena Investment Management LLC grew its position in MetLife by 22.9% during the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after buying an additional 2,211,315 shares during the period. Norges Bank purchased a new position in MetLife in the fourth quarter valued at $639,986,000. Finally, Invesco Ltd. raised its position in shares of MetLife by 2.6% in the fourth quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider’s stock worth $553,543,000 after acquiring an additional 176,811 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Trading Up 0.2%

Shares of MET stock opened at $96.83 on Wednesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a fifty-two week low of $67.33 and a fifty-two week high of $100.93. The stock has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. The company has a 50 day moving average price of $92.00 and a 200 day moving average price of $81.86.

MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. The business had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The company’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.02 earnings per share. Equities research analysts predict that MetLife, Inc. will post 9.7 EPS for the current fiscal year.

MetLife declared that its Board of Directors has approved a share buyback program on Wednesday, August 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to purchase up to 4.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be issued a dividend of $0.5925 per share. The ex-dividend date is Tuesday, August 4th. This represents a $2.37 annualized dividend and a yield of 2.4%. MetLife’s dividend payout ratio is 45.40%.

Analyst Ratings Changes

Several analysts have commented on MET shares. Weiss Ratings raised MetLife from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, June 15th. TD Cowen raised their target price on shares of MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $106.00 to $108.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Jefferies Financial Group increased their price target on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a research note on Friday, July 10th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $101.07.

Get Our Latest Stock Report on MET

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.